Abstract
Mathematical modelling suggests that it is theoretically possible to reduce risk of common diseases using heritable genome editing. Scientists argue that the technology involves considerable risk and uncertain benefits.
| Original language | English |
|---|---|
| Pages (from-to) | 554-556 |
| Number of pages | 3 |
| Journal | Nature |
| Volume | 637 |
| Issue number | 8046 |
| DOIs |
|
| State | Published - 16 Jan 2025 |
Bibliographical note
Publisher Copyright:© Springer Nature Limited 2025.
Keywords
- CRISPR-Cas9 genome editing
- Ethics